Evidence map›Paper›PMID 32517229›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis and In Vitro Cytotoxicity and Antibacterial Activity of Novel 1,2,3-Triazol-5-yl-phosphonates.

Anna Tripolszky, Emese Tóth, Pál Tamás Szabó, László Hackler, Beáta Kari, László G Puskás, Erika Bálint

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anna TripolszkyDepartment of Organic Chemistry and Technology, Budapest University of Technology and Economics, H1521 Budapest, Hungary.
Emese TóthDepartment of Organic Chemistry and Technology, Budapest University of Technology and Economics, H1521 Budapest, Hungary.
Pál Tamás SzabóMS Metabolomics Laboratory, Instrumentation Center, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok krt. 2., 1117 Budapest, Hungary.
László HacklerDepartment of Organic Chemistry and Technology, Budapest University of Technology and Economics, H1521 Budapest, Hungary.
Beáta KariAvidin Ltd., Alsó kikötő sor 11/D, H-6726 Szeged, Hungary.ORCID 0000-0002-4377-6824
László G PuskásAvidin Ltd., Alsó kikötő sor 11/D, H-6726 Szeged, Hungary.
Erika BálintAvidin Ltd., Alsó kikötő sor 11/D, H-6726 Szeged, Hungary.
Budapest University of Technology and Economics · HUHUN-REN Research Centre for Natural Sciences · HU

Funding

Hungarian Research Development and Innovation Office FK123961New National Excellence Program of the Ministry for Innovation and Technology ÚNKP-19-3-I-BME-391the János Bolyai Research Scholarship of the Hungarian Academy of Sciences BO/00278/17/7
6 · The paper itself

Abstract

Novel 1,2,3-triazol-5-yl-phosphonates were prepared by the copper(I)-catalyzed domino reaction of phenylacetylene, organic azides and dialkyl phosphites. The process was optimized on the synthesis of the dibutyl (1-benzyl-4-phenyl-1

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsBacteriaHumansNeoplasmsOrganophosphonatesStructure-Activity RelationshipTriazolesTumor Cells, CulturedAnti-Bacterial AgentsAntineoplastic AgentsOrganophosphonatesTriazoles1,2,3-triazolesanticancer activitycopper(I) catalystdomino reactionmulticomponent reactiontriazolyl phosphonates

Identifiers

PMID32517229
PMCPMC7321403
OpenAlexW3033252808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.